Le Lézard
Classified in: Ebola virus, Health, Covid-19 virus
Subjects: NPT, PER

Philanthropist Elaine Chambers Named Chair of the CDC Foundation's Board of Directors


ATLANTA, Dec. 13, 2022 /PRNewswire/ -- The CDC Foundation today announced that Elaine Chambers of the Chambers Family Foundation of Palo Alto, CA, has been named chair of the CDC Foundation Board of Directors. Chambers joined the CDC Foundation board in 2019.

"Elaine's passion and commitment to the power of public health and her experience in philanthropy make her an excellent leader for our board of directors as we work on long-term and emerging health threats that require cross-sector partnerships to address," said Judy Monroe, MD, president and CEO of the CDC Foundation. "As an organization, we will greatly benefit from Elaine's expertise and guidance as we work with board members, staff, donors, partners and the Centers for Disease Control and Prevention (CDC) to save and improve lives in America and across the globe."

Prior to the CDC Foundation, Chambers served as a board member with the Lucile Packard Foundation for Children's Health in Palo Alto, CA. In this role, she served as board chair for the foundation from 2015?2018. The foundation's mission is to elevate the priority of children's health and increase the quality and accessibility of children's healthcare. In addition, Chambers served on the Lucile Packard Children's Hospital Stanford board of directors from 2015?2018. This hospital is part of the only health system in the San Francisco Bay Area?and one of only few in the nation?that is exclusively dedicated to pediatric and obstetric care.

"My deep interest and passion have always been about improving the health of our communities, country and the world by supporting organizations and individuals who have the knowledge and expertise to make this happen," said Elaine Chambers, CDC Foundation board chair. "Developing relationships across all sectors of our society and being a vocal advocate for good health for all is so important. It is an honor to be involved with the CDC Foundation as it provides the perfect opportunity to support the greatest public health institution in our nation."

Chambers and her husband, John, are committed to helping others and have supported such institutions as the Children's Health Council, All Students Matter, the Mid-Peninsula Boys & Girls Club, Leading for Kids, the Stanford Women's Cancer Center and West Virginia University business, the American Heart Association and educational opportunities. Chambers is a graduate of West Virginia University and has a master's degree in Speech Pathology from The University of Memphis. 

Chambers succeeds Leah Devlin, DDS, MPH, professor of the Practice of Health Policy and Management, The University of North Carolina at Chapel Hill's Gillings School of Global Public Health, as chair of the CDC Foundation's Board of Directors.

About the CDC Foundation

The CDC Foundation helps the Centers for Disease Control and Prevention (CDC) save and improve lives by unleashing the power of collaboration between CDC, philanthropies, corporations, organizations and individuals to protect the health, safety and security of America and the world. The CDC Foundation is the go-to nonprofit authorized by Congress to mobilize philanthropic partners and private-sector resources to support CDC's critical health protection mission. Since 1995, the CDC Foundation has raised over $1.6 billion and launched more than 1,200 programs impacting a variety of health threats from chronic disease conditions including cardiovascular disease and cancer, to infectious diseases like rotavirus and HIV, to emergency responses, including COVID-19 and Ebola. The CDC Foundation managed hundreds of CDC-led programs in the United States and in more than 160 countries last year. Learn more at www.cdcfoundation.org.

SOURCE CDC Foundation


These press releases may also interest you

8 mai 2024
Tri-Tech Forensics, Inc. (Tri-Tech), a leading provider of tactical emergency medical solutions and human identification kits, is pleased to announce the acquisition of SAM® Medical (SAM Medical), a globally renowned provider of innovative medical...

8 mai 2024
The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.64 billion (USD 10.8 million1) in four projects for the development of new drugs for malaria and neglected tropical diseases (NTDs).2  The...

8 mai 2024
Renova Therapeutics, a biotechnology company developing gene therapy-based treatments for cardiovascular and metabolic diseases, announced today that it has focused its development and commercialization efforts for its RT-100 and RT-200 gene...

8 mai 2024
Organovo Holdings, Inc. ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches based on demonstration of clinical promise in three-dimensional (3D) human tissues, today announced the...

8 mai 2024
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology...

8 mai 2024
NCPDP announced today highlights from its 2024 Annual Technology & Business Conference, Innovation Starts Here. "NCPDP's standards and guidance are inherently innovative, and the work we continue to do will expand interoperability to support the...



News published on and distributed by: